Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
26 Apr 2006
UCB: Two European Regulatory Milestones for Keppra®
Read More
24 Apr 2006
UCB transfers back to Recordati the rights for the sale of Corifeo® (Lercanidipine) in Germany
Read More
31 Mar 2006
UCB - 2005 Annual Report on-line
Read More
31 Mar 2006
UCB - 2005 Annual Report on-line
Read More
14 Mar 2006
UCB - live analyst presentation
Read More
14 Mar 2006
UCB Full-Year 2005 Financial Results
Read More
2 Mar 2006
UCB Submits Biologics License Application to FDA for New Treatment in Crohn's Disease
Read More
23 Feb 2006
UCB Licenses Sepracor U.S. patents for antihistamine Levocetirizine
Read More
3 Feb 2006
UCB Receives EMEA Positive Opinion and FDA Approvable Letter for Keppra® (levetiracetam) Intravenous Administration
Read More
19 Jan 2006
UCB confirms good 2005 performance of Zyrtec in US and Xyzal
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
97
Page
98
Page
99
Page
100
Current page
101
Page
102
Page
103
Page
104
Page
105
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss